RxDoctor Payments Data

Emily Bugeaud, MD

Transplant Surgery · New Orleans, LANPI 1164683074

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,156 of the $1,780 with a category attached, or 64.9%. Intuitive Surgical accounts for 64.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $1,156 and has fallen 96.9% since, to $36 in 2025.

$1,780in general payments, 2019–2025

Across 13 payments — averaging $136.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$1K
  • Sanofi$209
  • Veloxis Pharmaceuticals, Inc.$207
  • Sanofi-aventis U.S. LLC$132
  • Organ Recovery Systems, Inc.$36
  • Abbott$20
  • plus $20 from 1 others

What the payments were for

  • Travel & lodging$1,15665%
  • Food & beverage$52429%
  • Education$1006%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few transplant surgery providers in Louisianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$38,895
Medicare patients
37
Services billed
67

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Valganciclovir Hcl34$3,628
Ursodiol14$569
Dapsone15$490
Pantoprazole Sodium18$312
Nifedipine ErNifedipine17$244
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim31$190
Prednisone15$44

Paid to pharmacies, not to this prescriber.

Other transplant surgery in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →